Prevention of Radiographic Progression in Higher-Risk Patients with Rheumatoid Arthritis Using Filgotinib in Phase III Studies: Narrative Review of Post Hoc Analyses

Abstract Filgotinib is an oral preferential Janus kinase 1 inhibitor that demonstrated significant reductions in radiographic progression, with an acceptable tolerability and safety profile, vs placebo in patients with rheumatoid arthritis (RA) and an inadequate response to methotrexate (MTX-IR; FIN...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Yoshiya Tanaka, Tsutomu Takeuchi, Tatsuya Atsumi, Bernard G. Combe, Daniel Aletaha, Toshihiko Kaise, Vijay Rajendran
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Adis, Springer Healthcare 2023-09-01
Reeks:	Rheumatology and Therapy
Onderwerpen:	Filgotinib Poor prognostic factors Adalimumab Methotrexate Rheumatoid arthritis
Online toegang:	https://doi.org/10.1007/s40744-023-00590-w
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!